Literature DB >> 8219651

Clinical significance of anaerobic bacteremias in a general hospital. A prospective study from 1988 to 1992.

J Gómez1, V Baños, J Ruiz, F Herrero, M Pérez, L Pretel, M Canteras, M Valdés.   

Abstract

A prospective study was designed to investigate anaerobic bacteremias and evaluate their incidence and significance in a general hospital. One or more blood cultures positive for anaerobic microorganisms were analyzed from each of a total of 61 patients hospitalized between January 1988 and April 1992, in accordance with an established protocol. The clinical repercussions of bacteremia were also analyzed. Two percent of blood cultures were positive for anaerobes, with an incidence of 0.6 cases per 1000 hospitalized patients. The most frequently isolated anaerobes were Bacteroides fragilis and Clostridium perfringens. Intraabdominal disease was the route of entry in 50% of the patients. A death rate of 37.3% was mostly attributed to B. fragilis. Hospitalization in the surgical department, nosocomial acquisition, previous surgery, critical initial clinical status and the presence of complications were significantly associated with increased death rates. No significant differences were found in the clinical course between patients whose antibiotic treatment was judged adequate and those for whom it was considered inadequate. The frequency and incidence of anaerobic bacteremia was low in our hospital. The well-known clinical and epidemiological characteristics of these infections facilitates their prompt diagnosis and empirical treatment with antibiotics of proven effectiveness against anaerobes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8219651     DOI: 10.1007/bf00184481

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  21 in total

1.  Anaerobic bacteremia: declining rate over a 15-year period.

Authors:  W R Gransden; S J Eykyn; I Phillips
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

2.  Anaerobic bacteremia in the elderly.

Authors:  M S Terpenning
Journal:  Gerontology       Date:  1989       Impact factor: 5.140

3.  Piperacillin therapy for serious bacterial infections.

Authors:  D J Winston; W Murphy; L S Young; W L Hewitt
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

4.  Anaerobic bacterial bacteremia: 12-year experience in two military hospitals.

Authors:  I Brook
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

5.  Susceptibility of isolates of Bacteroides to the bactericidal activity of normal human serum.

Authors:  D A Casciato; J E Rosenblatt; R Bluestone; L S Goldberg; S M Finegold
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

6.  Retrospective analysis of two hundred and twelve cases of bacteremia due to anaerobic microorganisms.

Authors:  E Bouza; M Reig; M Garcia de la Torre; M Rodríguez-Créixems; J Romero; E Cercenado; F Baquero
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

7.  Anaerobic bacteremia: decreasing rate over a 15-year period.

Authors:  C W Dorsher; J E Rosenblatt; W R Wilson; D M Ilstrup
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

8.  Anaerobic bacteremia in a general hospital: retrospective five-year analysis.

Authors:  F Vazquez; F J Mendez; F Perez; M C Mendoza
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

9.  Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.

Authors:  V M Bieluch; G J Cuchural; D R Snydman; S L Gorbach; F P Tally
Journal:  Diagn Microbiol Infect Dis       Date:  1987-06       Impact factor: 2.803

Review 10.  In vitro susceptibility vs. in vivo efficacy of various antimicrobial agents against the Bacteroides fragilis group.

Authors:  I Brook
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec
View more
  6 in total

1.  Controlled clinical comparison of BACTEC plus anaerobic/F to standard anaerobic/F as the anaerobic companion bottle to plus aerobic/F medium for culturing blood from adults.

Authors:  M L Wilson; S Mirrett; F T Meredith; M P Weinstein; V Scotto; L B Reller
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

3.  Are incidence and epidemiology of anaerobic bacteremia really changing?

Authors:  A Vena; P Muñoz; L Alcalá; A Fernandez-Cruz; C Sanchez; M Valerio; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-28       Impact factor: 3.267

4.  Retrospective analysis of risk factors and prognosis in non-ventilated patients with nosocomial pneumonia.

Authors:  J Gómez; A Esquinas; M D Agudo; J M Sánchez Nieto; M L Núñez; V Baños; M Canteras; M Valdes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

5.  Risk factors for mortality in patients with anaerobic bacteremia.

Authors:  J R Wilson; A P Limaye
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

6.  Epidemiology and outcome of nosocomial and community-onset bloodstream infection.

Authors:  D J Diekema; S E Beekmann; K C Chapin; K A Morel; E Munson; G V Doern
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.